Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus

Abstract

The objective was to study the response of cortisol and of prolactin (PRL) to specific stimuli in systemic lupus erythematosus (SLE). We measured the response of cortisol to insulin-induced hypoglycemia and of PRL to thyrotropin releasing hormone (TRH) in seven patients with active untreated SLE and in ten paired control subjects. All were women with regular menstrual cycles. With the exception of two patients, they had never received corticosteroids before the study.

The basal serum levels of cortisol (12.5 2.4 μg/dl) and PRL (10.7 1.0 ng/ml) in the SLE group were not significantly different from those of the control group (12.3 1.1 mg/dl and 13.7 2.4 ng =ml, respectively). The cortisol response after hypoglycemia was significantly lower in SLE patients compared to the control group at 45 min (P = 0.01), at 60 min (P = 0.009), and at 90 min (P = 0.001). The integrated cortisol response to hypoglycemia expressed as area under the response curve (AUC) did not differ significantly in either group (1447 187 vs 1828 84, P = 0.06). Although the peak of PRL after TRH did not differ significantly in both groups (68.0 7.4 ng =ml in SLE vs 66.3 77 ng/ml in controls) and the AUC of PRL response after TRH was comparable in both groups (4672 537 vs 4128 541, P = 0.32), the interval-specific ‘delta’ response was significantly higher in SLE than the control group at 0–60 min (P = 0.02) and 0–90 min (P = 0.01) after TRH injection.

These findings suggest that active SLE is associated with some degree of dysfunction of the hypothalamic-pituitary-glucocorticoid axis and PRL secretion.

Keywords

lupus cortisol prolactin hypothalamic-pituitary axis

Get full access to this article

View all access options for this article.

References

Reichlin S . Neuroendocrine-immune iterations . N Engl J Med 1993; 329: 1246–1253 .

Chrousos G . The hypothalamic-pituitary-adrenal axis and immune mediated inflammation . N Engl J Med 1995; 332: 1351–1362 .

Goetzl E . Mediators of communication and adaptation in the neuroendocrine and immune systems . FASEB 1992; 6: 2646–2652 .

Sternberg E et al. Inflammatory mediator-induced hypothalamic pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rat . Proc Natl Acad Sci 1989; 86: 2374–2378 .

Sternberg EM et al. A central nervous system defect in biosynthesis of corticotrophin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats . Proc Natl Acad Sci USA 1989; 86: 4771–4775 .

Schauenstein K et al. Disturbed immune-endocrine communication in autoimmune disease. Lack of corticosterone response to immune signals in obese strain chickens with spontaneous autoimmune thyroiditis . J Immunol 1987; 139: 1830–1833 .

Mason D , MacPhee I , Antoni F . The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat . Immunology 1990; 70: 1–5 .

Edwards C et al. The pituitary gland is required for protection against lethal effects of Salmonella Typhimurium . Proc Natl Acad Sci USA 1991; 88: 2274–2277 .

Jafarian TM et al. Interleukin-I receptor deficiency in brains from NZB and (NZB/NZW)F1 autoimmune mice . J Neuroimmunol 1994; 53: 91–99 .

10.

Jara LJ , Lavalle C , Espinoza LR . Does prolactin have a role in the pathogenesis of systemic lupus erythematosus? J Rheumatol 1992; 19: 1333–1336 .

11.

McMurray R et al. Prolactin influences autoimmune disease activity in the female B/W mouse . J Immunol 1991; 147: 3780–3787 .

12.

Jara LJ et al. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity . Am J Med Sci 1992; 303: 222–226 .

13.

Gutierrez MA et al. Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity . Lupus 1995; 4: 348–352 .

14.

Gutierrez MA et al. Prolactin-induced immunoglobulin and autoanti body production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals . Int Arch Allergy Immunol 1996; 109: 229–235 .

15.

Tan E , Cohen A , Fries J . The 1982 revised criteria of classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271–1277 .

16.

Sternberg EM . Neuroendocrine immune interactions: Principles and relevance to systemic lupus erythematosus. In: Wallace DJ and Hahn BH (eds) Dubois lupus erythmatosus. Williams & Willkins: Baltimore , 1997; 323–338.

17.

Orth DN , Kovacs WJ , Debold CR . Adrenal Cortex. In: Wilson JD and Foster DW (eds) Williams Textbook of Endocrinology WB Saunders Company: Philadelphia , 1992; 584–585.

18.

Lavalle C et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus . J Rheumatol 1987; 14: 268–272 .

19.

Folomeev M et al. Prolactin levels in men with SLE and RA . J Rheumatol 1990; 17: 1569–1570 (letter).

20.

Jara-Quezada L , Graef A , Lavalle C . Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus . J Rheumatol 1991; 18: 349–353 .

21.

Gutiérrez MA et al. Prolactin, a link between neuroendocrine and immune system. Its role in the pathogenesis of rheumatic diseases . Rev Rhum [Engl. Ed] 1994; 61: 261–267 .

22.

Jara LJ et al. Prolactin, immunoregulation, and autoimmune disease . Semin Arthritis Rheum 1991; 20: 273–284 .

23.

Mukherjee P , Mastro AM , Hymer WC . Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes . Endocrinology 1990; 126: 88–94 .

24.

Al-Janadi M et al. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases . J Clin Immunol 1993; 13: 58–67 .